Skip to content

SWILEM PHARMACEUTICALS: what changed

What changed

SWILEM PHARMACEUTICALS

BE 0640.994.707
NACE 70.200, Business and other management consultancy
filed annual accounts (NBB)
Financial years compared with
Net result for the year
-€7,783
2024 · -€8,135+€352
Equity
-€20,398
2024 · -€12,615-€7,783
Cash
€19,294
2024 · €11,045+€8,250
Balance sheet total
€292,979
2024 · €279,816+€13,164

Largest movements

2024 to 2025
Assets
  • Cash +€8,250

    up €8,250 (+74.7%), from €11,045 to €19,294

    mainly Depreciation (+€23,404) and Other debts (+€18,458)

Equity and liabilities
  • Other debts +€18,458

    up €18,458 (+99.5%), from €18,550 to €37,008

  • Trade debts +€9,146

    up €9,146 (+156%), from €5,872 to €15,018

  • Profit (loss) carried forward -€7,783

    down €7,783 (-38.6%), from -€20,156 to -€27,940

  • Debts after one year -€6,243

    down €6,243 (-2.6%), from €242,506 to €236,263

    of which Financial debts: -€6,243

Income statement
  • Other operating charges -€7,724

    down €7,724 (-62.1%), from €12,435 to €4,712

  • Write-downs +€5,534

    no longer reported in 2025 (was -€5,534)

  • Gross operating margin -€1,683

    down €1,683 (-5.3%), from €31,846 to €30,164

  • Depreciation +€803

    up €803 (+3.6%), from €22,602 to €23,404

  • Financial charges -€665

    down €665 (-6.4%), from €10,335 to €9,670

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€8,135
Gross operating margin -€1,683
Depreciation -€803
Write-downs -€5,534
Other operating charges +€7,724
Financial income -€25
Financial charges +€665
Taxes +€8
Result 2025 -€7,783
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€37,857
Investment -€25,869
Financing -€3,738
Cash 2024 €11,045
Net result for the year -€7,783
Depreciation +€23,404
Receivables within one year -€470
Deferred charges and accrued income -€1,979
Trade debts +€9,146
Tax, wage and social debts -€2,919
Other debts +€18,458
Investment in fixed assets (net) -€25,869
Debts after one year -€6,243
Current portion of long-term debt +€2,505
Cash 2025 €19,294
brings cash intakes cash out
Every line side by side 43 lines
Line Code 2024 2025 Change %
Total assets 20/58 €279,816 €292,979 +€13,164 +4.7%
Fixed assets 21/28 €259,238 €261,703 +€2,465 +1.0%
Tangible fixed assets 22/27 €258,977 €261,441 +€2,465 +1.0%
Land and buildings 22 €119,342 €121,678 +€2,336 +2.0%
Furniture and vehicles 24 €1,325 €19,912 +€18,586 +1,402%
Other tangible fixed assets 26 €138,310 €119,852 -€18,458 -13.3%
Financial fixed assets 28 €262 €262 = 0.0%
Current assets 29/58 €20,577 €31,276 +€10,699 +52.0%
Amounts receivable within one year 40/41 €8,648 €9,118 +€470 +5.4%
Trade receivables 40 €8,648 €9,118 +€470 +5.4%
Cash at bank and in hand 54/58 €11,045 €19,294 +€8,250 +74.7%
Deferred charges and accrued income 490/1 €885 €2,864 +€1,979 +224%
Total equity and liabilities 10/49 €279,816 €292,979 +€13,164 +4.7%
Equity 10/15 -€12,615 -€20,398 -€7,783 -61.7%
Contributions 10/11 €6,200 €6,200 = 0.0%
Reserves 13 €1,341 €1,341 = 0.0%
Non-distributable reserves 130/1 €1,341 €1,341 = 0.0%
Reserves not available under the articles 1311 €1,341 €1,341 = 0.0%
Profit (loss) carried forward 14 -€20,156 -€27,940 -€7,783 -38.6%
Amounts payable 17/49 €292,431 €313,378 +€20,947 +7.2%
Amounts payable after more than one year 17 €242,506 €236,263 -€6,243 -2.6%
Financial debts 170/4 €241,556 €235,313 -€6,243 -2.6%
Other amounts payable 178/9 €950 €950 = 0.0%
Amounts payable within one year 42/48 €49,925 €77,115 +€27,190 +54.5%
Current portion of amounts payable after more than one year 42 €20,618 €23,123 +€2,505 +12.2%
Trade debts 44 €5,872 €15,018 +€9,146 +156%
Suppliers 440/4 €5,872 €15,018 +€9,146 +156%
Taxes, remuneration and social security 45 €4,884 €1,965 -€2,919 -59.8%
Taxes 450/3 €4,884 €1,965 -€2,919 -59.8%
Other amounts payable 47/48 €18,550 €37,008 +€18,458 +99.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €22,602 €23,404 +€803 +3.6%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 -€5,534 - +€5,534
Other operating charges 640/8 €12,435 €4,712 -€7,724 -62.1%
Gross operating margin 9900 €31,846 €30,164 -€1,683 -5.3%
Operating profit (loss) 9901 €2,344 €2,048 -€296 -12.6%
Financial income 75/76B €25 - -€25
Recurring financial income 75 €25 - -€25
Financial charges 65/66B €10,335 €9,670 -€665 -6.4%
Recurring financial charges 65 €10,335 €9,670 -€665 -6.4%
Profit (loss) for the period before taxes 9903 -€7,966 -€7,623 +€344 +4.3%
Income taxes 67/77 €169 €161 -€8 -4.8%
Profit (loss) for the period 9904 -€8,135 -€7,783 +€352 +4.3%
Profit (loss) for the period to be appropriated 9905 -€8,135 -€7,783 +€352 +4.3%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.